Recent RAPT Stock Price | RAPT Stock Predictions | |
$4.66 | +438.84% |
$25.11 |
Recent RAPT Analyst Ratings Breakdown, Making RAPT Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 7 | 7 | 7 | 10 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 5 | 5 | 5 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.83 | 1.83 | 1.83 | 1.0 |
For the RAPT stock predictions from the analysts covering RAPT Therapeutics Inc, we have collected all of the individual RAPT stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 9 different analysts covering RAPT (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since RAPT stock predictions may vary widely, another useful metric to consider is the median RAPT stock prediction, which represents the price at which half of the analysts
made RAPT stock predictions that were higher and half made RAPT stock predictions that were lower. This makes for a different take on the RAPT stock predictions out there, as compared to average or mean.
And that median across all the individual RAPT stock predictions was: $18.0 as of 2024-05-10.
The very highest of the RAPT stock predictions for one year price target was $48.0, while the very lowest of the RAPT stock predictions in the analyst group was
$10.0 (with a standard deviation of $15.267). Get the latest Zacks research report on RAPT — FREE
Find out: RAPT next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
AVNT Stock Predictions
ROL Stock Predictions
SOL Stock Predictions
AVB Stock Predictions
CHKP Stock Predictions
FDUS Stock Predictions
CDW Stock Predictions
ABTX Stock Predictions
PEB Stock Predictions
|
|
Buy (3.17 out of 4) 42nd percentile
(ranked lower than approx. 58% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |